Unknown

Dataset Information

0

Poor Antigen Processing of Poxvirus Particles Limits CD4+ T Cell Recognition and Impacts Immunogenicity of the Inactivated Vaccine.


ABSTRACT: CD4+ T cells play critical roles in defending against poxviruses, both by potentiating cellular and humoral responses and by directly killing infected cells. Despite this central role, the basis for pox-specific CD4+ T cell activation, specifically the origin of the poxvirus-derived peptides (epitopes) that activate CD4+ T cells, remains poorly understood. In addition, because the current licensed poxvirus vaccines can cause serious adverse events and even death, elucidating the requirements for MHC class II (MHC-II) processing and presentation of poxviral Ags could be of great use. To address these questions, we explored the CD4+ T cell immunogenicity of ectromelia, the causative agent of mousepox. Having identified a large panel of novel epitopes via a screen of algorithm-selected synthetic peptides, we observed that immunization of mice with inactivated poxvirus primes a virtually undetectable CD4+ T cell response, even when adjuvanted, and is unable to provide protection against disease after a secondary challenge. We postulated that an important contributor to this outcome is the poor processability of whole virions for MHC-II-restricted presentation. In line with this hypothesis, we observed that whole poxvirions are very inefficiently converted into MHC-II-binding peptides by the APC as compared with subviral material. Thus, stability of the virion structure is a critical consideration in the rational design of a safe alternative to the existing live smallpox vaccine.

SUBMITTER: Forsyth KS 

PROVIDER: S-EPMC6394857 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Poor Antigen Processing of Poxvirus Particles Limits CD4<sup>+</sup> T Cell Recognition and Impacts Immunogenicity of the Inactivated Vaccine.

Forsyth Katherine S KS   DeHaven Brian B   Mendonca Mark M   Paul Sinu S   Sette Alessandro A   Eisenlohr Laurence C LC  

Journal of immunology (Baltimore, Md. : 1950) 20190130 5


CD4<sup>+</sup> T cells play critical roles in defending against poxviruses, both by potentiating cellular and humoral responses and by directly killing infected cells. Despite this central role, the basis for pox-specific CD4<sup>+</sup> T cell activation, specifically the origin of the poxvirus-derived peptides (epitopes) that activate CD4<sup>+</sup> T cells, remains poorly understood. In addition, because the current licensed poxvirus vaccines can cause serious adverse events and even death,  ...[more]

Similar Datasets

| S-EPMC8515144 | biostudies-literature
| S-EPMC2889742 | biostudies-other
2020-03-04 | PXD015012 | Pride
2020-03-04 | PXD015924 | Pride
| S-EPMC8425430 | biostudies-literature
| S-EPMC8282488 | biostudies-literature
| S-EPMC6010533 | biostudies-literature
| S-EPMC7461793 | biostudies-literature
| S-EPMC3382508 | biostudies-literature
| S-EPMC8000717 | biostudies-literature